Home > Healthcare > Medical Devices > Therapeutic Devices > Diabetes Care Devices Market

Diabetes Care Devices Market Size

  • Report ID: GMI3250
  • Published Date: Nov 2024
  • Report Format: PDF

Diabetes Care Devices Market Size

The global diabetes care devices market size was valued at around USD 45.1 billion in 2023 and is estimated to grow at 11.4% CAGR from 2024 to 2032. Diabetes care devices refer to a range of medical tools designed to monitor, manage, and treat diabetes. These devices include blood glucose meters, continuous glucose monitors (CGMs), insulin pumps, smart insulin pens, syringes, and lancets, each serving a critical role in helping individuals maintain optimal blood sugar levels and manage insulin therapy effectively.

 

The growing prevalence of diabetes across the world is the primary factor propelling the diabetes care devices market growth. For instance, according to the World Health Organization (WHO), in 2024, approximately 422 million people worldwide have diabetes, with the majority residing in low- and middle-income countries. Additionally, 1.5 million deaths are directly attributed to diabetes each year. This increasing incidence of diabetes is anticipated to fuel demand for effective management solutions, including continuous glucose monitoring, and insulin delivery devices. Consequently, this demand is likely to drive advancements in diabetes care devices to improve patient outcomes and enhance disease management.

 

Moreover, the market growth is driven by rising technological advancements in diabetes care devices and increasing investments by public and private organizations for diabetes care.

 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global diabetes care devices industry was valued at approximately USD 45.1 billion in 2023 and is estimated to grow at an 11.4% CAGR from 2024 to 2032, driven by advancements in diabetes management technologies.

The blood glucose monitoring devices segment dominated the market in 2023, accounting for a 58.4% market share and a CAGR of 11.6%, as they provide critical information for managing diet, exercise, and insulin dosing.

The U.S. market recorded USD 15.4 billion in 2023, driven by high healthcare expenditures and investments in advanced diabetes care technologies.

Key players in the sector include Abbott Laboratories, ARKRAY, Ascensia Diabetes Care Holding, B. Braun Melsungen, Becton, Dickinson and Company, Bionime Corporation, DarioHealth Corp., Dexcom, and Dr. Reddys Laboratories.

Diabetes Care Devices Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2023
  • Companies covered: 21
  • Tables & Figures: 324
  • Countries covered: 35
  • Pages: 145
 Download Free Sample